[{"Assets_0_FY_USD":4893700000.0,"EarningsPerShareBasic_1_FY_USD":0.62,"EarningsPerShareBasic_4_FY_USD":2.73,"EarningsPerShareDiluted_1_FY_USD":0.61,"EarningsPerShareDiluted_4_FY_USD":2.69,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":657200000.0,"NetIncomeLoss_1_FY_USD":60600000.0,"NetIncomeLoss_4_FY_USD":256300000.0,"PaymentsOfDividendsCommonStock_4_FY_USD":91500000.0,"StockholdersEquity_0_FY_USD":1181700000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":99300000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":93700000.0,"Ticker":"EHC","CIK":"785161","name":"ENCOMPASS HEALTH CORP","OfficialName":"Encompass Health Corporation Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"Our consolidated assets as of December 31, 2017 and December 31, 2016 include total assets of variable interest entities of $264.1 million and $262.3 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2017 and December 31, 2016 include total liabilities of the variable interest entities of $52.5 million and $50.3 million, respectively. See Note 3, Variable Interest Entities.","Market Cap":"7151596423.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20180228"}]